Claims Gain Traction

The most damaging path is that customers or former employees corroborate elevated failure rates, even if the exact ‘within 2 years’ claim remains disputed. Given Cerebras shares were already below IPO price, incremental evidence could trigger a sharp single-name repricing and contract scrutiny.

Each figure is the modeled move of the S&P 500 if the outcome occurs. For information only. Not investment advice.